Since the inception of Gründerfonds Ruhr in 2017, we have successfully financed and supported several portfolio companies which span across a wide range of our leading market sectors.
Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise immune responses and activate all relevant immune cell types against primary tumors and metastases. Led by experienced biotech entrepreneurs and immunology pioneers, Abalos’ goal is to achieve a quantum leap in immuno-oncology.
Based in Essen, Germany, Fasciotens GmbH was founded in 2016 by Dr. Gereon Lill and Dr. Frank Beyer and develops innovative products for surgery. As medical professionals, the Fasciotens founders are committed to maintaining direct contact with the medical staff at clinics who use their innovative product.
talpasolutions is a data science company based in Essen, Germany. talpasolutions has developed a software platform that connects machines, collects data, generates insights to optimize machine performance, minimizes downtime and helps companies in the mining and heavy industries comply with safety regulations. talpasolutions is a spin-off of RWTH Aachen University and was founded in 2016 by mining engineers and software experts. The focus is on data-driven decision support by miners for miners. To this end, talpasolutions offers innovative solutions and recommendations for action on process optimization for mine operators and machine manufacturers.
DIMATE, previously VISUS Industry IT, is an innovative and dynamic company based in Bochum, Germany, whose IT solutions lead materials testing into the digital future. With DIMATE PACS and DIMATE CCM, the company has developed a software that makes non-destructive and destructive testing in various industries safer and easier.
The affordable system was developed to intelligently lead and manage the transformation of analog processes to Industry 4.0 processes.
DIMATE products are based on globally recognized standards such as DICONDE, which enable extremely flexible use of the systems as test modalities can be connected to the system regardless of the manufacturer. In addition, the DIMATE software has a modular structure and thus adapts to the individual characteristics of all companies that use this platform.
Founded in 2017, the e-learning platform, Masterplan.com, is an operating system for education and lifelong learning in corporate settings. Using a combination of customizable learn paths and digital content, such as pre-recorded video seminars with leading national and international experts, users can design their own in-house experience. By providing a user friendly and entertaining environment, Masterplan aims to incentivize companies and its employees for more and better in-house training and promote state-of-the-art knowledge. In addition to its headquarters in Bochum, Masterplan.com has additional locations in Berlin and Vienna.
Founded in 2019, Emergence Therapeutics is a biotechnology company that develops novel antibody drug conjugates (ADCs) for the treatment of difficult-to-treat solid tumors. Using novel linker and payload technologies, the company aims to generate ADCs with improved efficacy and reduced side effects to minimize the risk of treatment resistance. The lead product candidate addresses Nectin-4, a clinically validated cancer target that is highly expressed by many different tumor types.
Emergence Therapeutics has entered into licensing agreements and collaborations with select partners and is supported by a team of senior industry experts and a strong consortium of renowned European investors.